Outpatient versus inpatient total shoulder arthroplasty: A cost and outcome comparison in a comorbidity matched analysis

Andrew Carbone, Alexander J. Vervaecke, Ivan B. Ye, Akshar V. Patel, Bradford O. Parsons, Leesa M. Galatz, Jashvant Poeran, Paul Cagle

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Background: Previous studies comparing total and reverse shoulder arthroplasty (TSA/RSA) are subject to surgeon selection bias. This study objective is to compare the outcomes and cost of outpatient TSA/RSA to inpatient TSA/RSA. Methods: 108,889 elective inpatient and outpatient TSA/RSA from Medicare claims data (2016–2018). 90-day readmission and total 90-day costs were compared following propensity score matching. Results: Younger and healthier patients are receiving outpatient TSA/RSA. Outpatient TSA/RSA was associated with fewer 90-day readmissions (OR 0.48 CI 0.38–0.59, p < 0.001) and lower 90-day costs (−20.1% CI -19.1%; −21.1%, p < 0.001). Conclusions: Outpatient TSA/RSA surgery offers lower complication rates and total costs. Level of evidence: III.

Original languageEnglish
Pages (from-to)126-133
Number of pages8
JournalJournal of Orthopaedics
Volume28
DOIs
StatePublished - 1 Nov 2021

Keywords

  • Ambulatory surgery center
  • Cost analysis
  • Outpatient
  • Readmission
  • Reverse shoulder arthroplasty
  • Total shoulder arthroplasty

Fingerprint

Dive into the research topics of 'Outpatient versus inpatient total shoulder arthroplasty: A cost and outcome comparison in a comorbidity matched analysis'. Together they form a unique fingerprint.

Cite this